Document Detail

Modification of chemotherapeutic effects on L1210 cells using hematoporphyrin and light.
MedLine Citation:
PMID:  6616462     Owner:  NLM     Status:  MEDLINE    
Tissue culture experiments were done to evaluate the possibility of modifying the response curves of phenylalanine mustard (LPAM) and actinomycin D on L1210 cells, using moderately toxic levels of photodynamic injury provided by light and hematoporphyrin (HP). Cells were grown and treated in Roswell Park Memorial Institute Medium 1630 containing 20% horse serum. Cells were incubated with HP at concentrations of 1 to 50 microM for up to 48 hr. Illumination was provided by fluorescent light (4 milliwatts/sq cm), filtered through plastic to remove all wavelengths outside of the range of 400 to 800 nm. Ambient light was carefully controlled. When cells were incubated with 25 microM HP in the dark for 24 hr and then exposed to light for 1 hr, there were reductions in cloning efficiencies of 30 to 80% compared to the dark-HP-treated controls. When LPAM (1 to 30 microM) or actinomycin D (0.04 to 2.0 ng/ml) was incubated with cells for 1 hr following HP treatment, with or without light exposure, the LPAM response curves were modified to indicate a synergistic response of photodynamic toxicity and chemotherapeutic toxicity (one additional log). HP in the dark prior to and during LPAM exposure did not modify the LPAM response curve. The actinomycin D response curve was modified by prior HP and light treatment to indicate an additive effect of one additional log; a synergistic effect may be present in the range of 100 to 10% cloning efficiencies. It is concluded that the L1210-HP-light system offers possibilities for investigating the modification of chemotherapy effects.
S P Creekmore; D S Zaharko
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Cancer research     Volume:  43     ISSN:  0008-5472     ISO Abbreviation:  Cancer Res.     Publication Date:  1983 Nov 
Date Detail:
Created Date:  1983-11-23     Completed Date:  1983-11-23     Revised Date:  2003-11-14    
Medline Journal Info:
Nlm Unique ID:  2984705R     Medline TA:  Cancer Res     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  5252-7     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Cell Division / drug effects
Cell Survival / drug effects
Clone Cells
Dactinomycin / therapeutic use*
Hematoporphyrins / therapeutic use*
Leukemia L1210 / therapy*
Melphalan / therapeutic use*
Reg. No./Substance:
0/Hematoporphyrins; 148-82-3/Melphalan; 50-76-0/Dactinomycin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Interrelation between tumor cell proliferation and 17-fluoresceinated estrone binding following prim...
Next Document:  Denitrosation as a determinant of nitrosocimetidine in vivo activity.